$QGEN Balance Sheet | Understand Stock

$QGEN

$50.37 -$0.02 (0.04%) Close

$QGEN Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of USD, except per-share amounts

	Q4 FY2025 As of Dec 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q4 FY2020 As of Dec 31, 2020	Q4 FY2019 As of Dec 31, 2019	Q4 FY2018 As of Dec 31, 2018	Q4 FY2017 As of Dec 31, 2017	Q4 FY2016 As of Dec 31, 2016	Q4 FY2015 As of Dec 31, 2015	Q4 FY2014 As of Dec 31, 2014	Q4 FY2013 As of Dec 31, 2013	Q4 FY2012 As of Dec 31, 2012	Q4 FY2011 As of Dec 31, 2011	Q4 FY2010 As of Dec 31, 2010
Assets
Current assets:
Cash and cash equivalents
Restricted cash
Short-term investments
Accounts receivable, net of allowance for credit losses of $19,538 and $18,226, respectively
Income taxes receivable
Inventories, net
Prepaid expenses and other current assets
Deferred income taxes
Fair value of derivative instruments - current
Total current assets

Long-term assets:
Property, plant and equipment, net of accumulated depreciation of $464,965 and $516,324, respectively
Goodwill
Intangible assets, net of accumulated amortization of $578,981 and $693,062, respectively
Deferred income taxes
Fair value of derivative instruments - long-term
Other long-term assets
Deferred tax assets
Total long-term assets

Total assets
Liabilities and equity
Current liabilities:
Current portion of long-term debt
Short-term loans
Accrued and other current liabilities
Income taxes payable
Deferred income taxes
Accounts payable
Fair value of derivative instruments - current
Accrued and other current liabilities (of which $15,404 and $5,488 due to related parties in 2019 and 2018, respectively)
Total current liabilities

Long-term liabilities:
Long-term debt, net of current portion
Deferred income taxes
Fair value of derivative instruments - long-term
Other long-term liabilities
Deferred tax liabilities
Total long-term liabilities

Equity:
Preference shares, 0.01 EUR par value, authorized—450,000 shares, no shares issued and outstanding
Financing preference shares, 0.01 EUR par value, authorized—40,000 shares, no shares issued and outstanding
Common Shares, 0.01 EUR par value, authorized—410,000 shares, issued—217,685 shares in 2025 and 223,904 in 2024
Additional paid-in capital
Retained earnings
Accumulated other comprehensive loss
Less treasury shares, at cost—764 and 1,614 shares, respectively
Total equity
Noncontrolling interest

Total liabilities and equity

Comments